The device uses two hundred small tactile biosensors that map the surface of the breast and monitor changes in texture, color and temperature.
One of the app features helps to manage, and track appointments, treatments, goals, tips, information, and what has worked for others in similar situations.
The Breast Cancer Weight Loss (BWEL) study will enroll nearly 3,200 overweight and obese women with early stage breast cancer.
The company's will license American Cancer Society's care guidance so that its Care Pros can give specialized care to clients diagnosed with cancer.
Researchers want to use the activity tracker to determine if it can help oncologists assess whether their patients are active enough for chemotherapy.
Called Breast Cancer Ally, the application was developed after gathering feedback from both specialists who cared for patients and patients themselves.
The app will help clinicians and patients manage side effects of hypertension and diarrhoea, which can be associated with therapy with cediranib and olaparib.
The device and its companion app turn pretty much any smartphone into a portable colposcope, making the screening process available all around the world.
Apple announced that researchers from Duke University, Johns Hopkins and Oregon Health & Science University are launching new medical studies using ResearchKit.
The smart mole scanner, which is designed to be attached to a smartphone's camera, is now live on crowdfunding website Indiegogo.